Wesbanco Bank Inc. increased its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,066 shares of the company’s stock after acquiring an additional 250 shares during the period. Wesbanco Bank Inc.’s holdings in Colgate-Palmolive were worth $1,370,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the 3rd quarter worth about $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $64,000. True Wealth Design LLC increased its stake in shares of Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC raised its position in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on CL shares. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. UBS Group decreased their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $101.11.
Insider Transactions at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.34% of the company’s stock.
Colgate-Palmolive Stock Performance
Shares of CL opened at $87.98 on Friday. The stock’s fifty day moving average price is $92.00 and its two-hundred day moving average price is $97.58. Colgate-Palmolive has a 1 year low of $80.03 and a 1 year high of $109.30. The firm has a market cap of $71.88 billion, a PE ratio of 25.21, a PEG ratio of 3.62 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Manufacturing Stocks Investing
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Consumer Discretionary Stocks Explained
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- ESG Stocks, What Investors Should Know
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.